Title
Category
Credits
Event date
Cost
  • Free-to-Member
  • Rapid Clinical Updates
  • 1.00 ABIM MOC Self Evaluation Points
  • 1.00 CME - AMA PRA Category 1 Credit™
  • 1.00 Non-physician
$95.00
This session is presented by Marci Laudenslager, MD, MHS, DABOM and Lily Ackermann, MD, ScM, FHM. Our moderator is Ebrahim Barkoudah, MD, FACP, MPH, SFHM. Obesity is projected to affect more than 50% of Americans by 2030 though, despite this epidemic, obesity remains chronically undertreated. Highly effective anti-obesity medications (e.g. GLP-1 receptor agonists) have revolutionized the landscape of obesity treatment and have the potential to close the obesity care gap. Participants will learn evidence-based obesity care strategies relevant for the hospitalized patient including how to manage GLP-1 receptor agonists. We will additionally discuss the broader societal impact of GLP-1s and review practical strategies to reduce weight bias and stigma in healthcare systems.
  • Free-to-Member
  • Rapid Clinical Updates
  • 1.00 ABIM MOC Self Evaluation Points
  • 1.00 CME - AMA PRA Category 1 Credit™
  • 1.00 Non-physician
$95.00
This session is presented by Megan Kamath, MD and Ebrahim Barkoudah, MD, FACP, MPH, SFHM. Our moderator is Lily Ackermann, ScM, MD, FACS, SFHM. This session explores cutting-edge interventions for end-stage heart failure patients, including mechanical circulatory support devices, cardiac transplantation evaluation criteria, and palliative care integration. We'll discuss patient selection for advanced therapies, review post-intervention management protocols, and examine recent outcome data. Case-based scenarios will illustrate decision-making pathways and multidisciplinary team approaches to optimize patient outcomes in this complex population.
  • Free-to-Member
  • Rapid Clinical Updates
  • 1.00 ABIM MOC Self Evaluation Points
  • 1.00 CME - AMA PRA Category 1 Credit™
  • 1.00 Non-physician
$95.00
This session is presented by Muthiah Vaduganathan, MD, MPH. Our moderators are Lily Ackermann ScM, MD, FACS, SFHM and Ebrahim Barkoudah, MD, FACP, MPH, SFHM. Join us for a special session on Cardio-Renal-Metabolic Disease and Care Models for Hospital Medicine. We are honored to have an internationally renowned expert to present the latest practice changing research that significantly impacts patient care. We will review the latest clinical trials and how they impact patient care and guideline-recommended use of nonsteroidal mineralocorticoid receptor antagonists (nsMRAs) for managing cardio-kidney-metabolic (CKM) conditions. There will be a review of the latest on the novel use of nsMRAs in patients with type 2 diabetes, cardiovascular disease, and CKD. We will discuss implications for inpatients and starting GDMT including the latest on the new nsMRAs in managing patients with heart failure, type 2 diabetes, and CKD.
  • Free-to-Member
$0.00
This is an EXCEL Continuing Education continuing medical education activity supported by an educational grant from Recordati Rare Disease.TARGET AUDIENCEThis activity is intended for hospitalists, emergency room physicians, pediatricians, hematologists, geneticists, genetic counselors, dermatologists, internal medicine and primary care physicians, registered nurses and nurse practitioners, and physician assistants.

Pages